Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer.
Loss of lean body mass as an independent risk factor for the continued development of S-1 adjuvant chemotherapy for gastric cancer